Wednesday, April 12, 2017

Ample Organics Brings Izenda's Embedded Self-Service BI and Analytics Platform to Licensed #Marijuana Industry

Ample Organics Brings Izenda's Embedded Self-Service BI and Analytics Platform to Licensed #Marijuana Industry


ATLANTA - April 12, 2017 (Investorideas.com Newswire) Izenda, a provider of a business intelligence (BI) and analytics platform purpose-built for OEM use and embedding, today announced an integration partnership with Ample Organics—the most widely adopted enterprise seed-to-sale platform in Canada.
Architected for compliance with Health Canada's Access to Cannabis for Medical Purposes Regulations, (ACMPR), Ample Organics is the enterprise software solution driving compliance at some of the world's largest and most sophisticated marijuana companies. Often referred to as ‘Seed-to-Sale' or ‘Track-and-Trace' software, Ample Organics is the infrastructure of the Canadian marijuana industry and serves as the system of record for controlled inventory at every stage of the manufacturing and fulfillment process in over 60 percent of licensed Canadian medical marijuana producers. Over 75,000 of the 120,000 medical marijuana patients across Canada are registered on the Ample Organics platform.
"We already operate in the most sophisticated medical marijuana market in the world and we're about to legalize," said John X. Prentice, president and CEO of Ample Organics. "Beyond the advantages business intelligence brings to our customers, we have the opportunity to leverage these massive datasets to better understand cannabis both as a medicine and as a business. What we will learn, and what Izenda enables our customers to learn, will shape the cannabis industry globally for years to come."
According to Scott Walters, CEO of MoreEtc, "John and his team continue to deliver outstanding integration and workflow efficiency across multiple regulated cannabis business environments in North America. As we develop new medical products and work with licensed growers, the ability to use Ample's operating system, risk management tools, and analytics for genetics gives us a unique advantage in finding revenue opportunities."
Ample Organics operates an extensive feature set built into a robust end-to-end tracking and reporting system. Izenda enables Ample Organics customers to easily analyze thousands of data points collected for improved quality assurance, operational efficiency, compliance, and generalized reporting. Many legacy reports will be migrated and offered in new interactive formats. Izenda's new easy-to-use interface will empower end-users to make data-driven decisions that will increase production capacity, better serve patients, and deeply analyze market trends.
About Ample Organics
Ample Organics is the most widely adopted seed-to-sale software solution among Canada's licensed medical marijuana producers, designed specifically for compliance with Health Canada's Access to Cannabis for Medical Purposes Regulations, or ACMPR.
About lzenda
Izenda offers an embedded self-service business intelligence (BI) and analytics platform purpose built for software companies, solutions providers and their customers. Izenda integrates seamlessly in applications to deliver BI and analytics directly to the people who need it most – application end users who want to easily analyze, visualize, and share valuable data and insights in real time.
Based in Atlanta, Ga. and founded in 2007, Izenda is used by more than 10,000 organizations on a daily basis. https://www.Izenda.com.
CONTACT:
Lauren Curley
(617) 529-6463
lauren@straight-linepr.com

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video
 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.